Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Two siblings both had a rare case of alopecia areata at the same time.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Yellow dots are common in severe alopecia areata.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.